# Low- and Very-Low-Calorie Diets and Medication Use in Hospitalized Patients with Obesity: A Cross-Sectional Study

**Authors:** Sérgio de Queiroz Braga, Márcia Cristina Almeida Magalhães Oliveira, Matheus Jorgetti Chamorro, Najara Araújo de Jesus, Rodrigo Almeida Magalhães Oliveira, Dandara Almeida Reis da Silva, Domingos Lázaro Souza Rios, Magno Merces

PMC · DOI: 10.3390/healthcare13111336 · 2025-06-04

## TL;DR

This study shows that low-calorie diets and lifestyle changes in hospitalized patients with severe obesity can reduce medication use, especially for high blood pressure.

## Contribution

The study demonstrates that inpatient multidisciplinary strategies with LCD/VLCD can reduce medication burden in severe obesity.

## Key findings

- Antihypertensive use decreased significantly from 74.4% at admission to 44.7% at 6 months.
- Average weight loss was 11% at 3 months and 21.3% at 6 months.
- Hypoglycemic prescriptions declined at 3 months but not at 6 months.

## Abstract

Background: Obesity is a growing global health concern associated with numerous comorbidities and high medication burden. This study aimed to evaluate the impact of low- and very-low-calorie diets (LCD/VLCD), combined with intensive lifestyle changes, on comorbidities and medication use in hospitalized patients with class II and III obesity. Methods: A retrospective cohort study was conducted using medical records of patients hospitalized for 3–6 months at a specialized obesity hospital in Brazil. Prescription data for antihypertensive, hypoglycemic, and lipid-lowering drugs were compared at admission, 3, and 6 months. Descriptive statistics, chi-squared tests, and t-tests were used to compare medication use and weight change over time. Results: Among 246 patients, the proportion of those using antihypertensives decreased from 74.4% at admission to 44.7% at 6 months (p < 0.02), with significant reductions also observed at 3 months (p < 0.001). Hypoglycemic prescriptions also declined at 3 months (p = 0.01), but not significantly at 6 months. Lipid-lowering medication use showed no significant changes. Average weight loss was 11% at 3 months and 21.3% at 6 months. Conclusions: Hospitalization with LCD/VLCD and lifestyle therapy was associated with a short-term reduction in medication burden, especially antihypertensives, supporting the potential of inpatient multidisciplinary strategies for severe obesity management.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Diseases:** weight (MESH:D015431), Obesity (MESH:D009765), LCD (MESH:C537881)
- **Chemicals:** Lipid-lowering medication (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12154314